Browse > Article

Modulation of Cell Proliferation and Hypertrophy by Gangliosides in Cultured Human Glomerular Mesangial Cells  

Lee Seoul (Department of Pharmacology, Wonkwang University School of Medicine)
Ahn Seon Ho (Division of Nephrology, Department of Internal Medicine, Wonkwang University School of Medicine)
Baek Seung Hoon (Division of Nephrology, Department of Internal Medicine, Wonkwang University School of Medicine)
Song Ju Hung (Division of Nephrology, Department of Internal Medicine, Wonkwang University School of Medicine)
Choo Young Kug (Division of Biological Science, College of Natural Science, Wonkwang University)
Kwon Oh Deog (College of Veterinary Medicine, Kyungpook National University)
Choi Bong Kyu (Department of Pharmacology, Wonkwang University School of Medicine)
Jung Kyu Yong (Department of Pharmacology, Wonkwang University School of Medicine)
Publication Information
Archives of Pharmacal Research / v.28, no.8, 2005 , pp. 948-955 More about this Journal
Abstract
Glomerular mesangial cells (GMCs) in diverse renal diseases undergo cell proliferation and/or hypertrophy, and gangliosides have been reported to play an important role in modulating cell structure and function. This study compared the effects of transforming growth $factor-\beta\; (TGF­\beta1)$ and the effects of the application of exogenous gangliosides on GMCs and investigated whether the application of exogenous gangliosides regulated cellular proliferation and hypertrophy. Human GMCs were cultured with exogenous gangliosides and $TGF-\beta1$ in a media containing $10\%$ fetal bovine serum and in a media without the fetal bovine serum. Exogenous gangliosides biphasically changed the proliferation of human GMCs (0.1-1.0 mg/mL). A low concentration (0.1 mg/mL) of gangliosides mainly increased the number of human GMCs, whereas cellular proliferation was significantly reduced by raising the concentration of exogenous gangliosides. $TGF-\beta1$ greatly reduced the number of human GMCs in a concentration­dependent manner (1-10 ng/mL). Serum deprivation accelerated the gangliosides- and $TGF­\beta1-induced$ inhibition of mesangial cell proliferation to a greater extent. Gangliosides (1.0 mg/ mL) and $TGF-\beta1$ (10 ng/mL) both caused a significant increase in the incorporation of $[^3H]leucine$ per cell in the serum-deprived condition, whereas it was completely reversed in serum­supplemented condition. Similar results to the $[^3H]leucine$ incorporation were also observed in the changes in cell size measured by flow cytometric analysis. These results show that exogenous gangliosides modulate cell proliferation and hypertrophy in cultured human GMCs, and these cellular responses were regulated differently based on whether the media contained serum or not. Results from the present study raise new possibilities about the potential involvement of gangliosides in the development of mesangial cell proliferation and hypertrophy.
Keywords
Gangliosides; Proliferation; Hypertrophy; Human glomerular mesangial cells;
Citations & Related Records

Times Cited By Web Of Science : 1  (Related Records In Web of Science)
Times Cited By SCOPUS : 1
연도 인용수 순위
1 Harth, S., Dreyfus, H., Urban, P. F., and Mandel, P., Direct thinlayer chromatography of gangliosides of total lipid extract. Anal. Biochem., 86, 543-551 (1978)   DOI   ScienceOn
2 Kagami, S., Kondo, S., Urushihara, M., Loster, K., Reutter, W., Saijo, T., Kitamura, A., Kobayashi, S., and Kuroda, Y., Overexpression of a1b1 integrin directly affects rat mesangial cell behavior. Kidney Int., 58, 1088-1097 (2000)   DOI   PUBMED   ScienceOn
3 Kwak, D. H., Rho, Y. I., Kwon, O. D., Ahn, S. H., Song, J. H., Choo, Y. K., Kim, S. J., Choi, B. K., and Jung, K. Y., Decrease of ganglioside GM3 in streptozotocin-induced diabetic glomeruli of rats. Life Sci., 72, 1997-2006 (2003)   DOI   ScienceOn
4 Mirkin, B. L., Clark, S. H., and Zhang, C., Inhibition of human neuroblastoma cell proliferation and EGF receptor phosphorylation by gangliosides GM1, GM3, GD1a, and GT1b. Cell Prolif., 35, 105-115 (2002)   DOI   ScienceOn
5 Morales, A., Colell, A., Mari, M., Garcia-Ruiz, C., and Fernandez-Checa, J. C., Glycosphingolipids and mitochondria: Role in apoptosis and disease. Glycoconj. J., 20, 579-588 (2004)   DOI   ScienceOn
6 Schwarzmann, G., Uptake and metabolism of exogenous glycosphingolipids by cultured cells. Semin. Cell Dev. Biol., 12, 163-171 (2001)   DOI   PUBMED   ScienceOn
7 Svennerholm, L., Quantitative estimation of sialic acid. II A colorimetric resorcinol-hydrochloride method. Biochim. Biophys. Acta, 4, 604-611 (1957)
8 Border, W. A. and Noble, N. A., TGF-beta in kidney fibrosis: A target for gene therapy. Kidney Int., 51, 1388-1396 (1997)   DOI   ScienceOn
9 Fujino, T., Yuhki, K., Yamada, T., Hara, A., Takahata, O., Okada, Y., Xiao, C. Y., Ma, H., Karibe, H., Iwashima, Y., Fukuzawa, J., Hasebe, N., Kikuchi, K., Narumiya, S., and Ushikubi, F., Effects of the prostanoids on the proliferation or hypertrophy of cultured murine aortic smooth muscle cells. Br. J. Pharmacol., 136, 530-539 (2002)   DOI   ScienceOn
10 Rho, Y. I., Kwak, D. H., Lee, S., Ahn, S. H., Baek, S. H., Song, J. H., Choo, Y. K., Choi, B. K., and Jung, K. Y., Mechanism for the negative regulation of cell proliferation bt ganglioside GM3 in high glucose-treated glomerular mesangial cells. Life Sci., 75, 51-62 (2004)   DOI   PUBMED   ScienceOn
11 Yamagishi, K., Mishima, K., Ohgami, Y., Iwasaki, K., Jimbo, M., Masuda, H., Igarashi, Y., Inokuchi, J., and Fujiwara, M., A synthetic ceramide analog ameliorates spatial cognition deficit and stimulates biosynthesis of brain gangliosides in rats with cerebral ischemia. Eur. J. Pharmacol., 462, 53-60 (2003)   DOI   PUBMED   ScienceOn
12 Simons, M., Friedrichson, T., Schulz, J. B., Pitto, M., Masserini, M., and Kurzchalia, T. V., Exogenous administration of gangliosides displaces GPI-anchored proteins from lipid microdomains in living cells. Mol. Biol. Cell, 10, 3187-3196 (1999)   DOI
13 Floege, J., Johnson, R. J., and Couser, W. G., Mesangial cells in the pathogenesis of progressive glomerular disease in animal model. Clin. Invest., 70, 857-864 (1992)
14 Masson, E., Wiernsperger, N., Lagarde, M., and El Bawab, S., Glucosamine induces cell-cycle arrest and hypertrophy of mesangial cells: implication of gangliosides. Biochem. J., 388, 537-544 (2005)   DOI   ScienceOn
15 Hakomori, S. and Igarashi, Y., Functional role of glycosphingolipids in cell recognition and signaling. J. Biochem., 118, 1091-1103 (1995)   DOI
16 Mahadevan, P., Larkins, R. G., Fraser, J. R., and Dunlop, M. E., Effects of prostaglandin $E_2$ and hyaluronan on mesangial cell proliferation: a potential contribution to glomerular hypercellularity in diabetes. Diabetes, 45, 44-50 (1996)   DOI   ScienceOn
17 Wolf, G., Cell cycle regulation in diabetic nephropathy. Kidney Int., 77, S59-S66 (2000)
18 Hakomori, S., Bifunctional role of glycosphingolipids: modulators for transmembrane signaling and mediators for cellular interactions. J. Biol. Chem., 265, 18713-18716 (1990)
19 Wolf, G. and Neilson, E. G., Angiotensin II induces cellular hypertrophy in cultured murine proximal tubular cells. Am. J. Physiol., 259, F768-F777 (1990)
20 Stephenson, L. A., Haney, L. B., Hussaini, I. M., Karns, L. R., and Glass II, W. F., Regulation of smooth muscle ${\alpha}$-actin expression and hypertrophy in cultured mesangial cells. Kidney Int., 54, 1175-1187 (1998)   DOI   PUBMED   ScienceOn
21 Tsuboi, N., Utsunomiya, Y., Kawamura, T., Kikuchi, T., Hosoya, T., Ohno, T., and Yamada, H., Shedding of growthsuppressive gangliosides from glomerular mesangial cells and undergoing apoptosis. Kidney Int., 63, 936-946 (2003)   DOI   ScienceOn
22 Shayman, J. A. and Radin, N. S., Structure and function of renal glycosphingolipids. Am. J. Physiol., 260, F291-F302 (1991)
23 Young, B. A., Johnson, R. J., Alpers, C. A., Eng, E., Gordon, K., Floege, J., and Couser, W. G., Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int., 47, 935- 944 (1995)   DOI   ScienceOn
24 Dubus, I., Vendrely, B., Christophe, I., Labouyrie, J. P., Delmas, Y., Bonnet, J., and Combe, C., Mycophenolic acid antagonizes the activation of cultured human mesangial cells. Kidney Int., 62, 857-867 (2002)   DOI   ScienceOn